In summary, this study establishes the FOSL1-PRMT1-CAPS axis as a central coordinator of radiotherapy resistance in GBM, integrating epigenetic regulation, RNA methylation, and DNA repair. This evidence concerns the gene FOSL1 and glioblastoma.